Multi Packaging Solutions wins ‘Packaging Company of the Year’

November 2, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Multi Packaging Solutions (“MPS”)(NYSE: MPSX),  a global market leader in healthcare, spirits, confectionery and media packaging, has been voted the …

Avacta joins major US cancer centre for CAR-T immunotherapy development

November 2, 2016
Research and Development Avacta, Memorial Sloan Kettering Cancer Center

Biotherapeutic and research reagent developer Avacta has announced it will collaborate with New York’s Memorial Sloan Kettering Cancer Center (MSK, …

gilead-sciences

Nimbus Therapeutics receives $200 million payment from Gilead

November 2, 2016
Research and Development Gilead Sciences, Nimbus Therapeutics, nash

Nimbus Therapeutics only signed a deal with Gilead Sciences back in April of this year and yet have already received …

ibm_web

Celgene partners with IBM for new pharmacovigilance platform

November 2, 2016
Research and Development, Sales and Marketing Celgene, Watson, ibm

IBM is set to join forces with Celgene to develop a new drug safety evaluation platform, it has emerged. Running …

valeant

Valeant looking at selling core asset to manage debt

November 2, 2016
Research and Development Takeda Pharmaceutical, Valeant pharmaceutical, salix

Valeant is rumoured to be looking into selling its Salix drugs business to Takeda Pharmaceutical, with figures floated of a …

Pfizer surprises industry by ending development of projected blockbuster

November 1, 2016
Research and Development Pfizer, cholesterol, clinical trials

Pfizer announced the news that it would no longer be developing an experimental cholesterol lowering drug. The drug had been …

cuba_us_flags

FDA approves clinical trial of Cuban lung cancer vaccine

November 1, 2016
Manufacturing and Production, Sales and Marketing Cuba, US, Vaccine, cimavax, clinical trials

The thawing of relations between the US and Cuba has allowed a pioneering treatment for non-small cell lung cancer to …

EMA has validated Merck and Pfizer’s MAA for avelumab

November 1, 2016
Manufacturing and Production, Sales and Marketing EMA, Merck KGaA, Pfizer, avelumab

The European Medicines Agency has validated the Marketing Authorisation Application for avelumab for the proposed indication of metastatic Merkel cell …

Woodley Equipment Company Exhibiting at Partnerships in Clinical Trials Europe 2016

November 1, 2016
PCT, clinical trials

Woodley Equipment Company is exhibiting at Partnerships in Clinical Trials Europe

Promising new study for children’s brain cancer

November 1, 2016
Manufacturing and Production brain cancer, children, oncology

There has been positive news coming from researchers at the Huntsman Cancer Institute, at the University of Utah, reporting on …

valeant

Hard times continue for Valeant as ex-CEO investigated for fraud

November 1, 2016
Manufacturing and Production CEO, Valeant, Valeant Pharmaceuticals, accounting, fraud

Valeant Pharmaceuticals continues to have a tough time after Bloomsberg broke the story of how former CEO J. Michael Pearson …

novartis_outside_1

Novartis breast cancer drug secures FDA fast-track status

November 1, 2016
Manufacturing and Production, Sales and Marketing Novartis, Pfizer, ibrance, letrozole, riboclib

Novartis has announced that its product ribociclib (LEE011) has been granted fast-track review status as a first-line treatment of advanced …

marc_weeks_takeda

Takeda appoint Marc Weeks to Digital Lead role

October 31, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, digital

Takeda UK have appointed Marc Weeks to the newly created role of digital lead. The creation of the role comes as …

Ashfield walks away with gold at EVCOM Clarion Awards

October 31, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield

The awards ceremony, held at The Seven Dials Club, Covent Garden, London on Friday 7 October, drew leading event and …

15813-a-senior-woman-receiving-a-vaccination-shot-from-her-doctor-pv

Influenza vaccine market to grow to £4.3 billion by 2025

October 31, 2016
Sales and Marketing influenza

GlobalData has released new findings which indicate that the seasonal influenza vaccine market is set to be worth $4.3 billion …

FDA rejects Sarilumab due to production facility issues

October 31, 2016
Manufacturing and Production, Sales and Marketing FDA, Regeneron, Sanofi, sarilumab

The US Food and Drugs administration has decided to reject the application for Sarilumab, Regeneron and Sanofi’s rheumatoid arthritis treatment, …

teva_copy

Teva sets out to delay generic competitor to Copaxone

October 31, 2016
Sales and Marketing Copaxone, Teva, Teva Pharmaceutical, generics

Teva Pharmacetuical, the Israel-based pharmaceutical company, submitted a document to the FDA on 30 October; the document outlines the differences …

astellas_tokyo_copy

Astellas snatches up oncology firm Ganymed for $1.4 billion

October 31, 2016
Research and Development, Sales and Marketing Astellas, Ganymed, IMAB362

Japanese pharma firm Astellas is set to bolster its oncology business with the acquisition of Ganymed Pharmaceuticals in a deal …

astrazeneca_logo_building

AstraZeneca’s head and neck cancer treatment clinical trials put on hold

October 31, 2016
Sales and Marketing AstraZeneca, clinical hold, clinical trials, immunotherapy, phase III

AstraZeneca, the Cambridge-based British company, had recruitment for its final stage Phase III trials placed on partial hold. The drug …

cynthia_chiaramitara

Novartis elects new MD for UK plant

October 28, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment

Novartis has named Cynthia Chiaramitara as managing director of its plant in Grimsby, UK. She will take on the role …

The Gateway to Local Adoption Series

Latest content